JOINT VENTURE (Details Narrative) - USD ($)		1 Months Ended			12 Months Ended
	Apr. 02, 2022	Jul. 25, 2023	May 17, 2022	May 31, 2021	Jun. 30, 2024	Jun. 30, 2023
Impairement of investment in joint venture						$ 156,460
Joint Venture With Movychem [Member]
Ownership owned percentage	50.00%
Contribution amount						312,919
XTI JV [Member]
Ownership owned percentage				50.00%
Initial Deposit				$ 5,500,000
Diluted equity interest			6.00%
Principal balance of the note and warrant			$ 6,050,000.00
Description of merger agreement		Inpixon filed an 8-K, announcing their intention to merge with XTI having executed an Agreement of Plan and Merger with XTI. The filing also showed that XTI had engaged in a transaction with Inpixon on March 10, 2023, receiving $300,000 in funding. Inpixon filed an S-4 registration statement on August 14, 2023
Description of recovery of losses					These include the recovery of losses, expenses, attorneys’ fees, punitive damages and a compensatory damage award exceeding $500 millio
Investment in joint venture					$ 5,500,000
Ebenberg LLC Joint Venture [Member]
Impairement of investment in joint venture						$ 156,460